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There has been growing interest in determining the
possible immune consequences of opioid administra-
tion for the management of postoperative pain. We
studied the effects of morphine and tramadol on pain
and immune function during the postoperative period
in 30 patients undergoing abdominal surgery for uter-
ine carcinoma. Phytohemoagglutinin-induced T lym-
phocyte proliferation and natural killer cell activity
were evaluated immediately before and after surgery,
and 2 h after the acute administration of either 10 mg of
morphine IM or 100 mg tramadol IM for pain. In all
patients, phytohemagglutinin-induced lymphoprolif-
eration was significantly depressed by surgical stress.
However, in the morphine-treated group, proliferative
values remained lower than basal levels for 2 h after
treatment, whereas in tramadol-administered patients
proliferative values returned to basal levels. Natural
killer cell activity was not significantly affected by sur-
gery nor by morphine administration, whereas tram-
adol significantly enhanced the activity of natural killer
cells. Both drugs produced a comparable reduction in
postoperative pain. We conclude that, as previously ob-
served in the experimental animal, tramadol and mor-
phine, when administered in analgesic doses, induce
different immune effects.
(Anesth Analg 2000;90:1411–4)
S everal studies conducted in animals and humanshave shown that opioids can exert immunosup-pressive effects (1–3). In particular, acute, as well
as chronic administration of morphine decreases lym-
phoproliferation, natural killer (NK) activity, macro-
phage functions, and the production of interferon-g
and interleukin-2 in the rodent (2). Consistent with
these observations, opioid administration has been
associated with increased susceptibility of animals to
bacterial and viral infections (4), and with decreased
survival in tumor-bearing animals (5). Similar effects
have been shown in humans, in which most studies
have been performed in IV-opioid abusers (4) and
relatively few in subjects exposed to opioids for ther-
apeutic reasons (6,7).
It is well known that the activation of endocrine and
sympathetic nervous systems during surgery leads to a
transient period of immunosuppression (8–10). The ther-
apeutic use of morphine might, therefore, be relatively
contraindicated in the postoperative period, in which the
functionality of the immune system is already compro-
mised by stress exposure. Tramadol is a centrally acting,
analgesic drug, with a double mechanism of action; it
binds with low affinity to m-opioid receptors, and acti-
vates central monoaminergic pathways inhibiting the
neuronal uptake of serotonin and noradrenaline (11,12).
We previously showed that, in mice, in contrast to mor-
phine, tramadol did not suppress cellular immune func-
tions, whereas it increased NK activity, lymphocyte pro-
liferation, and interleukin-2 production (13).
For all of these reasons, we wanted to study, in hu-
mans, the effects on immune responses of tramadol and
morphine administered for acute treatment of postoper-
ative pain in cancer patients. We evaluated the impact of
surgical stress and drug administration on two typical
immune functions, proliferation of T lymphocyte and
NK activity. Proliferation of T lymphocyte is a reliable
index of the ability of these cells to undergo clonal ex-
pansion after antigen stimulation, and NK cells are a
population of lymphocytes important in tumor surveil-
lance and in defense against viral infections (14).
Methods
A total of 30 patients undergoing abdominal surgery
for uterine carcinoma entered the study. These pa-
tients had never received radiotherapy, chemother-
apy, nor immunosuppressive drugs. After informed
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consent, and approval of the ethical committee of the
Department of Pharmacology, University of Milano,
Italy, patients were randomized into one of the two
study groups according to a computer-generated, ran-
domized list.
In all patients, after the IV induction with fentanyl
1 mg/kg, thiopental 5 mg/kg, and succinylcholine 1 mg/
kg, anesthesia was maintained with isoflurane 1.5–
1.7 minimum alveolar anesthetic concentration (% inspi-
ration 1.6:1.2 and % expiration 1.2:1.0), 66% nitrous oxide
in oxygen and pancuronium 0.07 mg/kg. Immediately
after the end of surgery, patients were given an IM
injection of either 10 mg of morphine HCl or 100 mg of
tramadol. At 2 h after the administration of morphine or
tramadol, pain was assessed by using visual analog scale
(VAS) (scores 0–100), and the degree of sedation was
evaluated by clinicians with scores from 0 to 4, where
0 5 awake, 1 5 easily aroused, 2 5 awakens after tactile
stimulation, 3 5 awakens after verbal stimulation, and
4 5 not arousable. Both evaluations were performed by
clinicians unaware of patient treatment group.
Blood was withdrawn before the beginning of sur-
gery, before drug administration, and 2 h after drug
administration. Blood was collected into tubes con-
taining EDTA. Peripheral blood mononuclear cells
were separated by gradient centrifugation over Ficoll-
Paque (Amersham Pharmacia Biotech, Milano, Italy)
as described by Manfredi et al. (15). Microcultures of
fresh peripheral blood mononuclear cells were set up
in triplicate for each sample (106 cells/mL) in RPMI
1640, 10% fetal calf serum with or without Phytohe-
moagglutinin (4, 1, and 0.25 mg/mL) (15).
Background values, (,1000 cpm), i.e., thymidine
incorporation by unstimulated cells, were subtracted
from values of mitogen-induced proliferation. NK cell
activity was evaluated by using a standard 4-h 51Cr-
release assay, with K562 cells as target cells (16,17).
51Cr-labeled K562 (target cells) were incubated with
splenocytes (effector cells) at effector/target cell ratios
of 100:1.
Specific 51Cr release was calculated according to the
formula:
100 3 @~experimental release 2 spontaneous release!/
~maximal release 2 spontaneous release!]
All of the immunological analysis were performed
in a blinded fashion by researchers unaware of patient
treatments. A sample size of 15 patients in each group
has 80% power to detect a difference of 1 sd between
the means of Group 1 and Group 2, assuming that the
common sd is 1 by using a two-tailed t-test with a 0.05
two-sided significance level. Demographic data of pa-
tients and VAS values were analyzed by using one-
way analysis of variance and the degree of sedation
measured by Mann-Whitney U-test. Lymphocyte pro-
liferation and NK activity were analyzed by using
mean of one-way analysis of variance for repeated
measures.
Results
Patient characteristics were homogeneous in the two
groups. Indeed, no statistical differences were ob-
served considering age (50 6 14 vs 51 6 15 yr), weight
(66 6 13 vs 65 6 13 kg), and the duration of surgery
(126 6 33 vs 122 6 35 min). No patient needed blood
transfusion during or after surgery.
The analgesic effects of acute tramadol and mor-
phine were similar; in fact, the VAS values 2 h after the
drug administration were not significantly different
(tramadol 44 6 19 mm; morphine 31 6 20 mm). There
was a comparable degree of sedation in the two treat-
ment groups (scores, 1.3 6 0.9 vs 1.6 6 0.8).
As shown in Figure 1, immediately after the end of
surgery, T lymphocyte proliferation was significantly
lower than basal proliferative levels in all patients. At
2 h after the injection of the analgesic drugs, a different
pattern of responses was observed in the two groups
of patients. In the morphine-treated patients (Figure 1,
left panel) lymphocyte proliferation was still signifi-
cantly lower than in basal conditions. In contrast, the
Phytohemoagglutinin-induced proliferation in the
group of patients treated with tramadol was not sig-
nificantly different from that observed before the be-
ginning of surgery, whereas a significant difference
was present in comparison with postsurgery values
(Figure 1, right panel).
NK cell activity was not impaired after the end of
surgery (Figure 2). However, morphine and tramadol
induced different effects on this immune variable.
Whereas a nonsignificant decrease of NK activity was
observed 2 h after morphine administration (Figure 2,
left), a significant increase of NK activity was present
in the group of patients treated with tramadol (Fig-
ure 2, right).
Discussion
We previously showed, in mice, that morphine and tra-
madol exerted different effects on immune responses.
Indeed, although morphine decreased lymphocyte pro-
liferation and NK activity (2), the same variables were
significantly enhanced by tramadol (13).
The current study was undertaken to evaluate
whether similar effects could be described in humans.
The postoperative period represents an interesting op-
portunity to address this problem, because it is known
that surgical stress results in activation of the
hypothalamic-pituitary-adrenal axis and the sympa-
thetic nervous system, leading to an alteration of im-
mune responses (8–10). Indeed, we observed a clear-cut
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decrease in T lymphocyte proliferation immediately af-
ter the end of surgery. Cancer patients enrolled in the
study were not immunosuppressed, and before the sur-
gical procedure, immune responses were comparable to
those described in healthy people (16,17).
The impaired response of T lymphocytes persisted
two hours after the administration of morphine,
whereby after the administration of tramadol the lym-
phoproliferation was not different in comparison with
presurgery values. Immunosuppression induced by
surgical stress has generally been shown to last longer
than two hours (18); however, from our study, it is
difficult to hypothesize whether the lymphoprolifera-
tion levels would have returned to normal values in
the absence of treatment with morphine.
We cannot say whether the apparently reestablished
levels of lymphoproliferation observed after tramadol
administration are caused by the immunostimulant
properties of this drug, as was observed in mice (13),
or the immune function was slowly returning to basal
levels and no interference by tramadol was present. In
any case, these findings indicate that tramadol does
not exert immunosuppressive actions.
In contrast to what was observed with lymphocyte
proliferation, surgery did not affect the cytotoxic ac-
tivity of NK cells. These two immune variables seem,
therefore, to show a different sensitivity to the stress
induced by this type of surgical procedure. Although
NK activity has generally been observed to be de-
creased after surgical stress (19,20), increased (21), as
well as unchanged (22), NK activity in the periopera-
tive period has also been reported. It is reasonable to
suggest that different surgical procedures can produce
different modifications of this variable. At two hours
after morphine administration, no significant alter-
ation of NK activity was present. Because it has been
shown that the immunosuppressive effects of mor-
phine are evident at doses larger than those needed
for controlling pain (2), it is likely that doses larger
than 10 mg of morphine are required to fully eviden-
tiate the suppression of NK activity in humans.
Whereas two hours after morphine administration
there was no significant modification of NK activity in
the group of patients treated with tramadol, a clear
and significant increase of this immune variable was
evident. These observations lead us to hypothesize a
stimulatory effect of tramadol on NK activity. Taken
together, these results confirm the pharmacological
properties of tramadol observed in the experimental
animal (13).
Morphine and tramadol share the opioid mecha-
nism of action, although the affinity of tramadol for
Figure 1. Phytohemoagglutinin (PHA)
(0.25, 1.0, 4.0 mg/mL) induced proliferation
of lymphocytes obtained from patients be-
fore the beginning of surgery (basal), imme-
diately after surgery and predrug (postsur-
gery), and 2 h after treatment with 10 mg of
morphine IM (left panel) or 100 mg of tra-
madol IM (right panel). Values are mean 6
sd. *P , 0.01 versus basal. 1P , 0.01 versus
postsurgery.
Figure 2. Natural killer cells activity obtained from patients before the
beginning of surgery (basal), immediately after surgery and predrug
(postsurgery), and 2 h after treatment with 10 mg of morphine IM or
100 mg of tramadol IM. Values are mean 6 sd. *P , 0.01 versus basal.
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m-opioid receptors is significantly lower than that of
morphine. However, the antinociceptive effects of tra-
madol are mediated also via a separate, nonopioid
mechanism, caused by the inhibition of neuronal up-
take of noradrenaline and serotonin (11,12). These dif-
ferences can account for the diverse pharmacody-
namic profile of morphine and tramadol on immune
functions.
The involvement of the noradrenergic and sero-
toninergic systems in neural-immune interactions has
been studied by using different experimental models.
Although both enhancement and reduction of im-
mune responses have been related to the activation
of the noradrenergic system (23), the increase of sero-
toninergic tone has usually been associated with
stimulation of NK activity and lymphocyte pro-
liferation (24,25). Consistent with these observations,
drugs which increase serotoninergic tone, such as
D-fenfluramine and fluoxetine, stimulate immune
function in rodents (24) and our unpublished results.
Moreover, in the mouse, we observed that the im-
mune effects of tramadol on lymphoproliferation and
NK activity were prevented by the administration of
the nonspecific serotoninergic antagonist metergoline
(25), indicating an involvement of the serotoninergic
system in the immune effects of this drug. Interest-
ingly, we have observed (our unpublished results)
that tramadol, when added in vitro to splenocyte cul-
tures, was not able to modulate either proliferation or
NK activity, thus eliminating a direct effect of the drug
on immune cells. Therefore, it can be suggested that
activation of the serotoninergic system might be in-
volved in the immune effects of tramadol in experi-
mental and clinical conditions.
In conclusion, we have confirmed in humans that
the immune function is differently affected by mor-
phine and tramadol. Analgesic drugs devoid of im-
munosuppressive effects might offer a good alterna-
tive to morphine for the treatment of postoperative
pain.
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